Boss; Anders Hasager
Patent Applications and Registrations
Patent applications and USPTO patent grants for Boss; Anders Hasager.The latest application filed is for "use of ultrarapid acting insulin".
- Boss; Anders Hasager - Princeton NJ
- Boss; Anders Hasager - Princenton NJ
| Patent | Date |
|---|---|
| Use of Ultrarapid Acting Insulin App 20210244800 - Boss; Anders Hasager ; et al. | 2021-08-12 |
| Use of ultrarapid acting insulin Grant 11,013,788 - Boss , et al. May 25, 2 | 2021-05-25 |
| Method Of Treating Diabetes Type 2 By Administering Ultrarapid Acting Insulin App 20210138040 - Richardson; Peter ; et al. | 2021-05-13 |
| Use of Ultrarapid Acting Insulin App 20200397868 - Boss; Anders Hasager ; et al. | 2020-12-24 |
| Method of treating diabetes type 2 by administering ultrarapid acting insulin Grant 10,857,207 - Richardson , et al. December 8, 2 | 2020-12-08 |
| Use of ultrarapid acting insulin Grant 10,772,935 - Boss , et al. Sept | 2020-09-15 |
| Superior Control Of Blood Glucose In Diabetes Treatment App 20200138912 - Cheatham; Wayman Wendell ; et al. | 2020-05-07 |
| Use of Ultrarapid Acting Insulin App 20190307853 - Boss; Anders Hasager ; et al. | 2019-10-10 |
| Use of ultrarapid acting insulin Grant 10,307,464 - Boss , et al. | 2019-06-04 |
| Use of Ultrarapid Acting Insulin App 20180303909 - Boss; Anders Hasager ; et al. | 2018-10-25 |
| Use of ultrarapid acting insulin Grant 10,046,031 - Boss , et al. August 14, 2 | 2018-08-14 |
| Method Of Treating Diabetes Type 2 By Administering Ultrarapid Acting Insulin App 20180185453 - Richardson; Peter ; et al. | 2018-07-05 |
| Use of ultrarapid acting insulin Grant 9,943,571 - Richardson , et al. April 17, 2 | 2018-04-17 |
| Potentiation of glucose elimination Grant 9,801,925 - Boss , et al. October 31, 2 | 2017-10-31 |
| Use of Ultrarapid Acting Insulin App 20170189492 - Boss; Anders Hasager ; et al. | 2017-07-06 |
| Use of Ultrarapid Acting Insulin App 20170143804 - Boss; Anders Hasager ; et al. | 2017-05-25 |
| Superior Control Of Blood Glucose In Diabetes Treatment App 20170087217 - Cheatham; Wayman Wendell ; et al. | 2017-03-30 |
| Use of ultrarapid acting insulin Grant 9,597,374 - Boss , et al. March 21, 2 | 2017-03-21 |
| Potentiation Of Glucose Elimination App 20150174210 - Boss; Anders Hasager ; et al. | 2015-06-25 |
| Potentiation of glucose elimination Grant 9,006,175 - Boss , et al. April 14, 2 | 2015-04-14 |
| Use of Ultrarapid Acting Insulin App 20140100158 - Richardson; Peter ; et al. | 2014-04-10 |
| Method of treating diabetes type 2 by administering ultrarapid acting insulin Grant 8,623,817 - Richardson , et al. January 7, 2 | 2014-01-07 |
| Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content Grant 8,258,095 - Boss , et al. September 4, 2 | 2012-09-04 |
| Use of Ultrarapid Acting Insulin App 20120122775 - Boss; Anders Hasager ; et al. | 2012-05-17 |
| Use of Ultrarapid Acting Insulin App 20120115777 - Richardson; Peter ; et al. | 2012-05-10 |
| Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin Grant 8,119,593 - Richardson , et al. February 21, 2 | 2012-02-21 |
| Superior Control of Blood Glucose in Diabetes Treatment App 20110183901 - Cheatham; Wayman Wendell ; et al. | 2011-07-28 |
| Superior control of blood glucose in diabetes treatment Grant 7,943,572 - Cheatham , et al. May 17, 2 | 2011-05-17 |
| Use Of Ultrarapid Acting Insulin App 20100035795 - Boss; Anders Hasager ; et al. | 2010-02-11 |
| Use Of Ultrarapid Acting Insulin App 20100035794 - Richardson; Peter ; et al. | 2010-02-11 |
| Method Of Preserving The Function Of Insulin-producing Cells App 20070027063 - Boss; Anders Hasager ; et al. | 2007-02-01 |
| Potentiation of glucose elimination App 20070020191 - Boss; Anders Hasager ; et al. | 2007-01-25 |
| Superior Control Of Blood Glucose In Diabetes Treatment App 20060239934 - Cheatham; Wayman Wendell ; et al. | 2006-10-26 |
| Methods and compositions for minimizing accrual of inhalable insulin in the lungs App 20060153778 - Gelber; Cohava ; et al. | 2006-07-13 |
| Method of reducing serum proinsulin levels in type 2 diabetics App 20050153874 - Cheatham, Wayman Wendell ; et al. | 2005-07-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 